Vega W A, Kolody B, Hwang J, Noble A
School of Public Health, Center for Community Health, University of California, Berkeley 94720.
N Engl J Med. 1993 Sep 16;329(12):850-4. doi: 10.1056/NEJM199309163291207.
Perinatal substance exposure has been linked to many neonatal and obstetrical complications. There have been few population-based epidemiologic studies to identify the prevalence and demographic profiles associated with drugs, alcohol, and smoking during pregnancy.
We studied a fully probabilistic stratified-cluster sample to estimate the prevalence of perinatal substance exposures in California in 1992. Urine samples from 29,494 women presenting for delivery in 202 hospitals were coded and screened for toxins; the results of toxicology screening were later linked by code number to the subjects' demographic variables and their reported use of tobacco and prescribed drugs. Urinary toxicologic tests provide conservative estimates because they can detect only very recent substance use.
The weighted prevalence for perinatal substance exposure was 5.16 percent for the use of one or more drugs, 6.72 percent for alcohol (analyzed independently), and 8.82 percent for self-reported smoking. The percentage of women testing positive for any drug, including alcohol, was 11.35 percent. Estimates for racial and ethnic groups varied widely. Black women had the highest prevalence of total drug use (14.22 percent), alcohol use (11.58 percent), cocaine use (7.79 percent), and tobacco use (20.12 percent). Most drug exposures occurred among white non-Hispanic and Hispanic women. White non-Hispanic women had the second highest prevalence rate for the use of one or more drugs (6.79 percent) and self-reported tobacco use (14.82 percent). Hispanic women had the second highest prevalence rate for alcohol (6.87 percent).
In California in 1992, there were 67,361 estimated perinatal exposures to one or more drugs, including alcohol, and 52,346 self-reported exposures to tobacco. These findings have clinical and public health implications.
围产期物质暴露与许多新生儿和产科并发症有关。很少有基于人群的流行病学研究来确定孕期药物、酒精和吸烟的患病率及人口统计学特征。
我们研究了一个完全概率分层整群样本,以估计1992年加利福尼亚州围产期物质暴露的患病率。对202家医院29494名分娩妇女的尿液样本进行编码并筛查毒素;毒理学筛查结果随后通过编码与受试者的人口统计学变量及其报告的烟草和处方药使用情况相联系。尿液毒理学检测提供的是保守估计,因为它们只能检测到最近的物质使用情况。
使用一种或多种药物的围产期物质暴露加权患病率为5.16%,酒精(单独分析)为6.72%,自我报告吸烟为8.82%。检测出任何药物(包括酒精)呈阳性的女性比例为11.35%。不同种族和族裔群体的估计差异很大。黑人女性的总药物使用(14.22%)、酒精使用(11.58%)、可卡因使用(7.79%)和烟草使用(20.12%)患病率最高。大多数药物暴露发生在非西班牙裔白人女性和西班牙裔女性中。非西班牙裔白人女性使用一种或多种药物(6.79%)和自我报告吸烟(14.82%)的患病率排名第二。西班牙裔女性的酒精患病率排名第二(6.87%)。
1992年在加利福尼亚州,估计有67361例围产期暴露于一种或多种药物(包括酒精),52346例自我报告暴露于烟草。这些发现具有临床和公共卫生意义。